IL153921A0 - Use of il-8 receptor antagonists in the treatment of virus infections - Google Patents

Use of il-8 receptor antagonists in the treatment of virus infections

Info

Publication number: IL153921A0
Authority: IL; Israel
Prior art keywords: treatment; receptor antagonists; virus infections; infections; virus
Prior art date: 2000-07-18

Application number

IL15392101A

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-18

Filing date

2001-07-16

Publication date

2003-07-31

2001-07-16 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2003-07-31 Publication of IL153921A0 publication Critical patent/IL153921A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL15392101A 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections IL153921A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21905300P	2000-07-18	2000-07-18
PCT/US2001/022328 WO2002005814A1 (en)	2000-07-18	2001-07-16	Use of il-8 receptor antagonists in the treatment of virus infections

Publications (1)

Publication Number	Publication Date
IL153921A0 true IL153921A0 (en)	2003-07-31

Family

ID=22817645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15392101A IL153921A0 (en)	2000-07-18	2001-07-16	Use of il-8 receptor antagonists in the treatment of virus infections

Country Status (17)

Country	Link
EP (1)	EP1307190A4 (en)
JP (1)	JP2004509852A (en)
KR (1)	KR20030019587A (en)
CN (1)	CN1449285A (en)
AR (1)	AR033830A1 (en)
AU (1)	AU2001273497A1 (en)
BR (1)	BR0112603A (en)
CA (1)	CA2418162A1 (en)
CZ (1)	CZ2003132A3 (en)
HU (1)	HUP0300754A3 (en)
IL (1)	IL153921A0 (en)
MX (1)	MXPA03000500A (en)
NO (1)	NO20030201L (en)
NZ (1)	NZ523659A (en)
PL (1)	PL365886A1 (en)
WO (1)	WO2002005814A1 (en)
ZA (1)	ZA200300474B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2007001561A (en) *	2004-08-04	2007-04-16	Schering Corp	Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases.
WO2015173701A2 (en) *	2014-05-12	2015-11-19	Glaxosmithkline Intellectual Property (No. 2) Limited	Pharmaceutical compositions for treating infectious diseases
US20230141355A1 (en) *	2020-03-26	2023-05-11	Dompe' Farmaceutici Spa	Cxcl8 inhibitors for use in the treatment of covid-19
EP3884932A1 (en) *	2020-03-26	2021-09-29	Dompe' Farmaceutici S.P.A.	Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) *	2020-12-02	2022-06-08	Dompe' Farmaceutici S.P.A.	Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5547979A (en) *	1992-03-30	1996-08-20	Smithkline Beecham	TNF inhibition
AU3539795A (en) *	1994-08-25	1996-03-14	Medical University Of South Carolina	Methods of treating cold symptoms using pentoxifylline
WO1996025157A1 (en) *	1995-02-17	1996-08-22	Smithkline Beecham Corporation	Il-8 receptor antagonists
SE9802729D0 (en) *	1998-08-13	1998-08-13	Astra Pharma Prod	Novel Compounds
SE9802937D0 (en) *	1998-09-01	1998-09-01	Astra Pharma Prod	Novel compounds

2001
- 2001-07-16 IL IL15392101A patent/IL153921A0/en unknown
- 2001-07-16 KR KR10-2003-7000717A patent/KR20030019587A/en not_active Application Discontinuation
- 2001-07-16 CZ CZ2003132A patent/CZ2003132A3/en unknown
- 2001-07-16 NZ NZ523659A patent/NZ523659A/en unknown
- 2001-07-16 MX MXPA03000500A patent/MXPA03000500A/en unknown
- 2001-07-16 BR BR0112603-2A patent/BR0112603A/en not_active IP Right Cessation
- 2001-07-16 JP JP2002511746A patent/JP2004509852A/en not_active Withdrawn
- 2001-07-16 CN CN01813095A patent/CN1449285A/en active Pending
- 2001-07-16 AR ARP010103395A patent/AR033830A1/en not_active Application Discontinuation
- 2001-07-16 WO PCT/US2001/022328 patent/WO2002005814A1/en active Application Filing
- 2001-07-16 AU AU2001273497A patent/AU2001273497A1/en not_active Abandoned
- 2001-07-16 PL PL01365886A patent/PL365886A1/en not_active Application Discontinuation
- 2001-07-16 HU HU0300754A patent/HUP0300754A3/en unknown
- 2001-07-16 EP EP01952777A patent/EP1307190A4/en not_active Withdrawn
- 2001-07-16 CA CA002418162A patent/CA2418162A1/en not_active Abandoned
2003
- 2003-01-15 NO NO20030201A patent/NO20030201L/en not_active Application Discontinuation
- 2003-01-17 ZA ZA200300474A patent/ZA200300474B/en unknown

Also Published As

Publication number	Publication date
CZ2003132A3 (en)	2003-09-17
ZA200300474B (en)	2004-08-17
HUP0300754A3 (en)	2009-03-02
NO20030201D0 (en)	2003-01-15
AR033830A1 (en)	2004-01-07
BR0112603A (en)	2004-08-24
AU2001273497A1 (en)	2002-01-30
JP2004509852A (en)	2004-04-02
EP1307190A4 (en)	2007-08-22
NZ523659A (en)	2006-01-27
PL365886A1 (en)	2005-01-10
CA2418162A1 (en)	2002-01-24
MXPA03000500A (en)	2003-06-24
EP1307190A1 (en)	2003-05-07
CN1449285A (en)	2003-10-15
KR20030019587A (en)	2003-03-06
NO20030201L (en)	2003-03-17
WO2002005814A1 (en)	2002-01-24
HUP0300754A2 (en)	2003-08-28

Publication	Publication Date	Title
EE05507B1 (en)	2012-02-15	Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia
MXPA03004915A (en)	2003-09-05	Mch antagonists and their use in the treatment of obesity.
HK1056877A1 (en)	2004-03-05	Mch antagonists and their use in the treatment of obesity.
HUS1300015I1 (en)	2021-05-28	Antibodies to human il-1beta
DE60124863D1 (en)	2007-01-11	AGAINST HUMAN INTERLEUKIN-1-BETA RECOMBINANT ANTIBODIES
IL141034A0 (en)	2002-02-10	Uracil compounds and use thereof
PT1317485E (en)	2011-07-06	Myostatin antagonists and uses thereof
DE60033055D1 (en)	2007-03-08	LUMBAR TREATMENT DEVICE
MXPA03005744A (en)	2003-09-05	Piperidine mch antagonists and their use in the treatment of obesity.
MXPA03004439A (en)	2003-08-19	Aminothiazoles and their use as adenosine receptor antagonists.
HUP0301308A3 (en)	2010-01-28	Human papilloma virus treatment
EE200200484A (en)	2004-04-15	Low dose entecavir preparation and its use
IL152700A0 (en)	2003-06-24	Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists
IL153708A0 (en)	2003-07-06	Benzimidazole derivatives, preparation and therapeutic use thereof
HK1061212A1 (en)	2004-09-10	Pyranoindazoles and their use for the treatment ofglaucoma
HUP0300599A3 (en)	2003-09-29	Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
HK1074446A1 (en)	2005-11-11	3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
GB0105613D0 (en)	2001-04-25	Pharmaceutically effective compounds and their use
AU9279601A (en)	2002-04-08	Compounds and methods for use thereof in the treatment of cancer or viral infections
IL153921A0 (en)	2003-07-31	Use of il-8 receptor antagonists in the treatment of virus infections
HUP0300470A3 (en)	2005-05-30	Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
EP1322319A4 (en)	2005-08-31	Use of il-8 protein modulators in the treatment of viral infections
ZA200403530B (en)	2005-07-28	Chemokine receptor antagonists and methods of use thereof.
AU2002336782A8 (en)	2006-11-02	Penis vibrator
HUP0300305A3 (en)	2005-05-30	Il-8 receptor antagonists, pharmaceutical compositions containing them and their use